Impact of arterial stiffness on all-cause mortality in patients hospitalized with COVID-19 in Spain
…, A Gonzalez Noya, A Suarez-Lombrana… - …, 2021 - Am Heart Assoc
Older age and cardiovascular comorbidities are well-known risk factors for all-cause mortality
in patients with coronavirus disease 2019 (COVID-19). Hypertension and age are the 2 …
in patients with coronavirus disease 2019 (COVID-19). Hypertension and age are the 2 …
[HTML][HTML] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers withdrawal is associated with higher mortality in hospitalized patients with COVID …
…, JN Alcalá, A Suárez-Lombraña… - Journal of Clinical …, 2021 - mdpi.com
Our main aim was to describe the effect on the severity of ACEI (angiotensin-converting
enzyme inhibitor) and ARB (angiotensin II receptor blocker) during COVID-19 hospitalization. A …
enzyme inhibitor) and ARB (angiotensin II receptor blocker) during COVID-19 hospitalization. A …
Clinical and Subclinical Arteriosclerotic Disease in Octagenarians With Hip Fracture. A Case–Control Study.
…, C Sierra-Benito, V Sapena, A Suárez-Lombraña… - 2022 - researchsquare.com
Background: Osteoporosis and cardiovascular diseases share risk factors and pathophysiological
mechanisms. Hip fracture and cardiovascular diseases are very common in older …
mechanisms. Hip fracture and cardiovascular diseases are very common in older …
Effect of in-hospital treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on mortality and complications in patients …
…, BC Rodríguez, JN Alcalá, A Suárez-Lombraña… - medRxiv, 2021 - medrxiv.org
Background The use of ACEI (Angiotensin-Converting Enzyme Inhibitor) and ARB (Angiotensin
II Receptor Blocker) in COVID-19 remains controversial. Our main aim was to describe …
II Receptor Blocker) in COVID-19 remains controversial. Our main aim was to describe …
[HTML][HTML] Risk categories in COVID-19 based on degrees of inflammation: data on more than 17,000 patients from the Spanish SEMI-COVID-19 Registry
(1) Background: The inflammation or cytokine storm that accompanies COVID-19 marks the
prognosis. This study aimed to identify three risk categories based on inflammatory …
prognosis. This study aimed to identify three risk categories based on inflammatory …
[HTML][HTML] Prior treatment with statins is associated with improved outcomes of patients with COVID-19: data from the SEMI-COVID-19 Registry
JD Torres-Peña, LM Pérez-Belmonte… - Drugs, 2021 - Springer
Background The impact of statins on COVID-19 outcomes is important given the high
prevalence of their use among individuals at risk for severe COVID-19. Our aim is to assess …
prevalence of their use among individuals at risk for severe COVID-19. Our aim is to assess …
[HTML][HTML] Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry
JM Casas-Rojo, JM Antón-Santos… - Revista Clínica …, 2020 - Elsevier
Background Spain has been one of the countries most affected by the COVID-19 pandemic.
Objective To create a registry of patients with COVID-19 hospitalized in Spain in order to …
Objective To create a registry of patients with COVID-19 hospitalized in Spain in order to …
[HTML][HTML] Autoimmune diseases and COVID-19 as risk factors for poor outcomes: data on 13,940 hospitalized patients from the Spanish nationwide SEMI-COVID-19 …
MM Ayala Gutierrez, M Rubio-Rivas… - Journal of clinical …, 2021 - mdpi.com
(1) Objectives: To describe the clinical characteristics and clinical course of hospitalized
patients with COVID-19 and autoimmune diseases (ADs) compared to the general population. (2…
patients with COVID-19 and autoimmune diseases (ADs) compared to the general population. (2…
[HTML][HTML] Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study
J Lora-Tamayo, G Maestro, A Lalueza… - The Journal of …, 2021 - ncbi.nlm.nih.gov
Outcomes for patients with COVID-19 infection have been widely reported for the initial peak
of the pandemic. 1 However, there is a lack of data describing outcomes and characteristics …
of the pandemic. 1 However, there is a lack of data describing outcomes and characteristics …
Patients with COPD hospitalized due to COVID-19 in Spain: a comparison between the first and second wave
M Gómez-Antúnez, A Muiño-Míguez… - Revista Clínica …, 2023 - Elsevier
Objective This work aimed to compare the characteristics, progress, and prognosis of
patients with COPD hospitalized due to COVID-19 in Spain in the first wave with those of the …
patients with COPD hospitalized due to COVID-19 in Spain in the first wave with those of the …
